New Products

  • Product Details

Product Information


Product name

NanoActive Resveratrol (RES)



Quality Standard

5% by HPLC


 Yellow, viscous and transparent liquid


Soluble in water and oil, heated to over 40, dissolution-rate will be accelerated


COA of NanoActive Resveratrol (RES)






Light yellow, viscous liquid


Diluted in water (1: 50)

Colorless or light yellow and transparent solution



Characteristic Smell


Assay (HPLC)



pH (in 1:50 aqueous solution)



Density (20ºC)

1.0 – 1.1 g/cm3


Heavy Metal




Soluble in water and oil, heated to over 40 ℃,


dissolution rate will be accelerated

Total aerobic bacteria

< 10 CFU/g


Molds and Yeasts

< 10 CFU/g


pathogenic bacteria



Conclusion:  Conformed to specification.




Resveratrol (Res) is a non-flavonoid polyphenol compound. Resveratrol has a wide range of anti-cancer, anti-oxidation, antibacterial, anti-inflammatory activities. It can be widely used in medicine, health care products, food, cosmetics and other fields. Resveratrol highly works on many targets on the skin. As a new high- efficiency natural active substance, it can achieve good whitening, anti-wrinkle, anti-inflammation, antibacterial, acne treatment and anti-aging functions in skin care products. But disadvantages of resveratrol which is hard to dissolve in water, easily oxygenated and easy discoloration limit its application in cosmetics.

NanoActive Res, with a particle size of less than 30nm developed by the nano-delivery system (NSD),  completely solve the problems of dissolution of Resveratrol. Resveratrol that stably wrapped in nano-carriers can greatly increase the absorption efficiency and bioavailability.

Resveratrol inhibits melanin synthesis by multiple targets

Product Efficacy of NanoActive Res

1. NanoActive Res can promote collagen synthesis, increase skin thickness and elasticity, remove wrinkles and tighten skin.
2. NanoActive Res inhibits melanin synthesis, reduces pigmentation and whitens skin
3. Remove free radicals to fight oxidation and anti-skin aging
4. NanoActive Res Promotes wound healing and reduces scarring
5. Cure acne and reduce acne pit
6. Antibacterial, anti-inflammatory, anti - sensitive and analgesia;

7. Prevent scarring and fibrosis

Low concentration of resveratrol (0.001%) reduced the melanin content of B16F10 cells by 50%

Resveratrol has an obvious anti-wrinkle effect

Recommended Quantity: 1-5%. The optimal pH range of the system is 3.0-6.5. The finished product should avoid direct sunlight (using opaque packaging). It is recommended to add UV absorbent to daycare products
Product storage: avoid light preservation under 25 ℃

Send A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Related Products

In-house Specification
LIRAGLUTIDE 204656-20-2
Product Information Product name Liraglutide Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu- Glu-Gly-Gln-Ala-Ala-Lys[N6-[N-(1-oxohexadecyl)-L-γ-glutamyl]- -Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH CAS No. 204656-20-2 Molecular Formula C172H265N43O51 Molecular Weight 3751.20 Storage  2~8℃ Appearance White to off-white crystalline powder COA of Liraglutide Test Specification Results Appearance: White to off-white crystalline powder or lumps White powder Identity: 3751.2±1.0 3751.1 Purity (By HPLC) : Not Less than 98.0%; 99.51% Residual solvents: ≤0.25%total; ≤0.1%individual; ≤0.01%CH2CN Complies Related Peptide Total Impurity ≤ 2.0% Largest Single Impurity ≤ 1.0% TI =0.41% LSI =0.25% Peptide Content: Not Less than 85.0% 87.7% Water (K.F.): Not more than 5% 4.2% Acetate acid: Not more than 10% 8.1% Bacterial Endotoxins Not more than 50IU/mg Complies Usage Function and Usage of Liraglutide 204656-20-2 1、 Type 2 diabetes Liraglutide improves control of blood glucose.It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion. In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over more traditional therapies for type 2 diabetes: ·         Liraglutide acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk of hypoglycemia. ·         Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies). ·         Liraglutide decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride. ·         Liraglutide lowers blood triglyceride levels. 2、Obesity Liraglutide has been approved as an injectable adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients. The specified criteria are an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight), in the presence of at least one weight-related comorbid condition (e.g.hypertension, type 2 diabetes mellitus, or dyslipidemia). In late 2014, data were reported from the SCALE™ Obesity and Prediabetes trial, which is a randomised, double-blind, placebo-controlled, multinational trial in non-diabetic people with obesity and non-diabetic people who are overweight with comorbidities. In this phase 3a trial, there were 3,731 participants randomised to treatment with liraglutide 3 mg or placebo, both in combination with diet and exercise. Those who completed the 56-week trial achieved an average weight loss of 9.2%, to be compared with a 3.5% reduction in the placebo group.
TRAVOPROST 157283-68-6
99% up, USP32
IVY LEAF EXTRACT Supplier -Sinoway
nsf-GMP , HACCP , Kosher , HALAL
Send A Message
Send A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.